These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9751421)

  • 1. Development of step-specific PET tracers for studying fatty acid beta-oxidation: biodistribution of [1-(11)C] octanoate analogs in rats and a cat.
    Kawashima H; Kuge Y; Yajima K; Miyake Y; Hashimoto N
    Nucl Med Biol; 1998 Aug; 25(6):543-8. PubMed ID: 9751421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [1-11C]octanoate as a potential PET tracer for studying glial functions: PET evaluation in rats and cats.
    Kuge Y; Kawashima H; Yamazaki S; Hashimoto N; Miyake Y
    Nucl Med Biol; 1996 Nov; 23(8):1009-12. PubMed ID: 9004290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and preliminary evaluation of (18)F-labeled 4-thia palmitate as a PET tracer of myocardial fatty acid oxidation.
    DeGrado TR; Wang S; Holden JE; Nickles RJ; Taylor M; Stone CK
    Nucl Med Biol; 2000 Apr; 27(3):221-31. PubMed ID: 10832078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain uptake and metabolism of [1-11C]octanoate in rats: pharmacokinetic basis for its application as a radiopharmaceutical for studying brain fatty acid metabolism.
    Kuge Y; Yajima K; Kawashima H; Yamazaki H; Hashimoto N; Miyake Y
    Ann Nucl Med; 1995 Aug; 9(3):137-42. PubMed ID: 8534586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-cyclopentadienyltricarbonyl 99mtc 8-oxooctanoic acid: a novel radiotracer for evaluation of medium chain fatty acid metabolism in the liver.
    Lee BC; Choe YS; Chi DY; Paik JY; Lee KH; Choi Y; Kim BT
    Bioconjug Chem; 2004; 15(1):121-7. PubMed ID: 14733591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evaluation of [1-11C]octanoate as a PET tracer for studying cerebral ischemia: a PET study in rat and canine models of focal cerebral ischemia.
    Kuge Y; Kawashima H; Hashimoto T; Imanishi M; Shiomi M; Minematsu K; Hasegawa Y; Yamaguchi T; Miyake Y; Hashimoto N
    Ann Nucl Med; 2000 Feb; 14(1):69-74. PubMed ID: 10770584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of [1-11C]octanoate as a new radiopharmaceutical for assessing liver function using positron emission tomography.
    Yamamura N; Magata Y; Kitano H; Konishi J; Saji H
    Nucl Med Biol; 1998 Jul; 25(5):467-72. PubMed ID: 9720664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro uptake of [1-14C]Octanoate in brain slices of rats: basic studies for assessing [1-11C]Octanoate as a PET tracer of glial functions.
    Kuge Y; Hikosaka K; Seki K; Ohkura K; Nishijima K; Tsukamoto E; Tamaki N
    Nucl Med Biol; 2002 Apr; 29(3):303-6. PubMed ID: 11929699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary evaluation of 15-[18F]fluoro-3-oxa-pentadecanoate as a PET tracer of hepatic fatty acid oxidation.
    DeGrado TR; Wang S; Rockey DC
    J Nucl Med; 2000 Oct; 41(10):1727-36. PubMed ID: 11038005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 13C isotopomer n.m.r. method for monitoring incomplete beta-oxidation of fatty acids in intact tissue.
    Gavva SR; Wiethoff AJ; Zhao P; Malloy CR; Sherry AD
    Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):847-53. PubMed ID: 7980454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic brain distribution of 1-(14)C-octanoate in a rat model of focal cerebral ischemia in comparison with those of (123)I-IMP and (123)I-iomazenil.
    Kuge Y; Hikosaka K; Seki K; Ohkura K; Nishijima KC; Kaji T; Ueno S; Tsukamoto E; Tamaki N
    J Nucl Med; 2003 Jul; 44(7):1168-75. PubMed ID: 12843233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-[18F]fluorooctanoic acid and its beta-substituted derivatives as potential agents for cerebral fatty acid studies: synthesis and biodistribution.
    Nagatsugi F; Sasaki S; Maeda M
    Nucl Med Biol; 1994 Aug; 21(6):809-17. PubMed ID: 9234330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids.
    DeGrado TR; Kitapci MT; Wang S; Ying J; Lopaschuk GD
    J Nucl Med; 2006 Jan; 47(1):173-81. PubMed ID: 16391202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle.
    Takala TO; Nuutila P; Pulkki K; Oikonen V; Grönroos T; Savunen T; Vähäsilta T; Luotolahti M; Kallajoki M; Bergman J; Forsback S; Knuuti J
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1617-22. PubMed ID: 12458396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [1-11C]Octanoate as a PET tracer for studying ischemic stroke: evaluation in a canine model of thromboembolic stroke with positron emission tomography.
    Kuge Y; Kawashima H; Minematsu K; Hasegawa Y; Yamaguchi T; Miyake Y; Hashimoto T; Imanishi M; Shiomi M; Tamaki N; Hashimoto N
    Biol Pharm Bull; 2000 Aug; 23(8):984-8. PubMed ID: 10963308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-beta-oxidizable omega-[18F]fluoro long chain fatty acid analogs show cytochrome P-450-mediated defluorination: implications for the design of PET tracers of myocardial fatty acid utilization.
    DeGrado TR; Moka DC
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):389-97. PubMed ID: 1629027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of [11C]hemicholinium-15 and [18F]hemicholinium-15 as new potential PET tracers for the high-affinity choline uptake system in the heart.
    Gao M; Miller MA; DeGrado TR; Mock BH; Lopshire JC; Rosenberger JG; Dusa C; Das MK; Groh WJ; Zipes DP; Hutchins GD; Zheng QH
    Bioorg Med Chem; 2007 Feb; 15(3):1289-97. PubMed ID: 17116396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of radioiodinated medium chain fatty acids as new diagnostic agents for the determination of hepatic viability.
    Yamamura N; Magata Y; Konishi J; Saji H
    Eur J Nucl Med; 1999 Dec; 26(12):1597-605. PubMed ID: 10638412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octanoate oxidation measured by 13C-NMR spectroscopy in rat skeletal muscle, heart, and liver.
    Walton ME; Ebert D; Haller RG
    J Appl Physiol (1985); 2003 Nov; 95(5):1908-16. PubMed ID: 12882988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging.
    Shoup TM; Elmaleh DR; Bonab AA; Fischman AJ
    J Nucl Med; 2005 Feb; 46(2):297-304. PubMed ID: 15695790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.